Corium to Present at 15th Annual Needham Healthcare Conference
MENLO PARK, Calif. , March 31, 2016 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that Peter Staple , Corium’s President and…

Corium Announces Positive Preclinical Results with Long-acting Potent GLP-1 Analog Delivered in MicroCor^® Transdermal Patch
Research Conducted with Calibr and TSRI Published in PNAS Demonstrates the Potential to Improve Treatment with a Therapeutic Peptide…